Ameritas Investment Partners, Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,300
-25.1%
6,1940.0%0.00%
Q2 2023$11,087
-54.0%
6,1940.0%0.00%
-100.0%
Q1 2023$24,095
+19.7%
6,1940.0%0.00%0.0%
Q4 2022$20,131
-39.0%
6,1940.0%0.00%0.0%
Q3 2022$33,000
+22.2%
6,1940.0%0.00%0.0%
Q2 2022$27,000
-41.3%
6,1940.0%0.00%
-50.0%
Q1 2022$46,000
+15.0%
6,1940.0%0.00%
+100.0%
Q4 2021$40,000
+11.1%
6,1940.0%0.00%0.0%
Q3 2021$36,000
-43.8%
6,1940.0%0.00%
-50.0%
Q2 2021$64,000
-1.5%
6,1940.0%0.00%0.0%
Q1 2021$65,000
-32.3%
6,1940.0%0.00%
-50.0%
Q4 2020$96,000
+6.7%
6,1940.0%0.00%0.0%
Q3 2020$90,000
-23.1%
6,1940.0%0.00%
-33.3%
Q2 2020$117,000
+13.6%
6,194
+16.0%
0.01%0.0%
Q1 2020$103,000
+9.6%
5,338
+9.3%
0.01%
+50.0%
Q4 2019$94,000
+100.0%
4,8860.0%0.00%
+100.0%
Q3 2019$47,000
+95.8%
4,886
+21.6%
0.00%
+100.0%
Q2 2019$24,000
+4.3%
4,0190.0%0.00%0.0%
Q1 2019$23,000
-39.5%
4,0190.0%0.00%
-50.0%
Q4 2018$38,000
-44.1%
4,0190.0%0.00%
-33.3%
Q3 2018$68,0000.0%4,0190.0%0.00%0.0%
Q2 2018$68,000
+70.0%
4,019
+35.5%
0.00%
+50.0%
Q1 2018$40,000
+42.9%
2,9670.0%0.00%
+100.0%
Q4 2017$28,000
-6.7%
2,9670.0%0.00%0.0%
Q3 2017$30,000
+11.1%
2,9670.0%0.00%0.0%
Q2 2017$27,000
+17.4%
2,967
+66.5%
0.00%0.0%
Q1 2017$23,0001,7820.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders